Comparison of NN5401 With Insulin Glargine in Insulin Naive Subjects With Type 2 Diabetes
Status:
Completed
Trial end date:
2011-09-01
Target enrollment:
Participant gender:
Summary
This trial is conducted in Japan. The aim of this trial is to investigate the efficacy and
safety of NN5401 (insulin degludec/insulin aspart) with insulin glargine in subjects with
type 2 diabetes in Japan. Depending on pre-trial oral anti-diabetic drugs (OADs), subjects
continued at the same dose and dosing frequency.